Anthony Aliquo
CIK: 0002149586
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NERV
Minerva Neurosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Aliquo Anthony
Aliquo Anthony (SEC CIK 0002149586) files insider reports with the SEC as Chief Accounting Officer of Minerva Neurosciences, Inc. (NERV).
Signal8 holds 1 ownership filing by Aliquo Anthony, a Form 3, filed on Aug 20, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Aliquo Anthony's filings is in BURLINGTON, MA.
Other insiders filing for Minerva Neurosciences, Inc. (NERV)
- Kaul Inderjit, Director
- Reilly Joseph H., Chief Operating Officer
- Ahlholm Frederick W, SVP, CFO and Secretary
- Luthringer Remy, CEO
- Laghrissi-Thode Fouzia, Director
- Kupfer David, Director